0|chunk|Perspective of Use of Antiviral Peptides against Influenza Virus
0	22	31 Antiviral	Chemical	CHEBI_22587
0	32	40 Peptides	Chemical	CHEBI_16670
0	CHEBI-CHEBI	CHEBI_22587	CHEBI_16670

1|chunk|The threat of a worldwide influenza pandemic has greatly increased over the past decade with the emergence of highly virulent avian influenza strains. The increased frequency of drug-resistant influenza strains against currently available antiviral drugs requires urgent development of new strategies for antiviral therapy, too. The research in the field of therapeutic peptides began to develop extensively in the second half of the 20 th century. Since then, the mechanisms of action for several peptides and their antiviral prospect received large attention due to the global threat posed by viruses. Here, we discussed the therapeutic properties of peptides used in influenza treatment. Peptides with antiviral activity against influenza can be divided into three main groups. First, entry blocker peptides such as a Flupep that interact with influenza hemagglutinin, block its binding to host cells and prevent viral fusion. Second, several peptides display virucidal activity, disrupting viral envelopes, e.g., Melittin. Finally, a third set of peptides interacts with the viral polymerase complex and act as viral replication inhibitors such as PB1 derived peptides. Here, we present a review of the current literature describing the antiviral activity, mechanism and future therapeutic potential of these influenza antiviral peptides.
1	239	248 antiviral	Chemical	CHEBI_22587
1	239	254 antiviral drugs	Chemical	CHEBI_36044
1	249	254 drugs	Chemical	CHEBI_23888
1	305	314 antiviral	Chemical	CHEBI_22587
1	370	378 peptides	Chemical	CHEBI_16670
1	479	485 action	Chemical	CHEBI_5133
1	498	506 peptides	Chemical	CHEBI_16670
1	517	526 antiviral	Chemical	CHEBI_22587
1	653	661 peptides	Chemical	CHEBI_16670
1	691	699 Peptides	Chemical	CHEBI_16670
1	705	714 antiviral	Chemical	CHEBI_22587
1	802	810 peptides	Chemical	CHEBI_16670
1	946	954 peptides	Chemical	CHEBI_16670
1	1051	1059 peptides	Chemical	CHEBI_16670
1	1133	1143 inhibitors	Chemical	CHEBI_35222
1	1164	1172 peptides	Chemical	CHEBI_16670
1	1241	1250 antiviral	Chemical	CHEBI_22587
1	1323	1332 antiviral	Chemical	CHEBI_22587
1	1333	1341 peptides	Chemical	CHEBI_16670
1	CHEBI-CHEBI	CHEBI_22587	CHEBI_36044
1	CHEBI-CHEBI	CHEBI_22587	CHEBI_23888
1	CHEBI-CHEBI	CHEBI_22587	CHEBI_16670
1	CHEBI-CHEBI	CHEBI_22587	CHEBI_5133
1	CHEBI-CHEBI	CHEBI_22587	CHEBI_35222
1	CHEBI-CHEBI	CHEBI_36044	CHEBI_23888
1	CHEBI-CHEBI	CHEBI_36044	CHEBI_16670
1	CHEBI-CHEBI	CHEBI_36044	CHEBI_5133
1	CHEBI-CHEBI	CHEBI_36044	CHEBI_35222
1	CHEBI-CHEBI	CHEBI_23888	CHEBI_16670
1	CHEBI-CHEBI	CHEBI_23888	CHEBI_5133
1	CHEBI-CHEBI	CHEBI_23888	CHEBI_35222
1	CHEBI-CHEBI	CHEBI_16670	CHEBI_5133
1	CHEBI-CHEBI	CHEBI_16670	CHEBI_35222
1	CHEBI-CHEBI	CHEBI_5133	CHEBI_35222

